Viewing Study NCT01587703

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:25 PM
Ignite Modification Date: 2026-06-25 @ 7:34 AM
Study NCT ID: NCT01587703
Status: COMPLETED
Last Update Posted: 2020-03-16
First Post: 2012-04-03
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: A Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of GSK525762 in Subjects With NUT Midline Carcinoma (NMC) and Other Cancers
Sponsor: GlaxoSmithKline
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Carcinoma, Midline View
Keywords:

Keywords

Keyword Brief Keyword Text View
None BRD3 View
None GSK525762 View
None NUT Midline Carcinoma View
None MYCN-amplified Solid Tumor View
None BRD4 View
None BET inhibitor View
None bromodomains View
None NMC View
None Colorectal C ancer View
None Small Cell Lung Cancer View
None Multiple Myeloma View
None Neuroblastoma View
None Oncology View